don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Uromigos","authorlink":""},"src":"https:\/\/anchor.fm\/s\/13347ea8\/podcast\/play\/50743617\/https:\/\/d3ctxlq1ktw2nl.cloudfront.net\/staging\/2022-3-18\/48792205-b06d-88bb-48ba-68540ee80612.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202206\/9aed5f-417e-e2ab-039fa5_800.jpg"},"title":"Episode 166: Prostate cancer debate: doublet vs triplet first line therapy","link":"javascript:;","id":"item-13825781"}]
